这项交易最初是在去年6月份公布,Coty 计划为 KKW Beauty 扩展现有产品线,引入新的美容品类,包括在 2022 财政年度推出首个护肤系列。(详见《华丽志...查看全文
$Nabi Biopharmaceuticals(NABI)$ PREC14A - Preliminary proxy statements, contested solicitations Filed: 2018-01-12 AccNo: 0000921895-18-000146 Size: 348 KB 网页链接
$Nabi Biopharmaceuticals(NABI)$ 425 - Prospectuses and communications, business combinations Filed: 2018-01-12 AccNo: 0001437749-18-000555 Size: 2 MB 网页链接
$Nabi Biopharmaceuticals(NABI)$ 8-K - Current report Filed: 2018-01-12 AccNo: 0001437749-18-000554 Size: 2 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Nabi Biopharmaceuticals(NABI)$ EFFECT - Notice of Effectiveness Filed: 2017-12-29 AccNo: 9999999995-18-000015 Size: 2 KB 网页链接
$Nabi Biopharmaceuticals(NABI)$ S-4/A [Amend] - Registration of securities, business combinations Filed: 2017-12-29 AccNo: 0001437749-17-021271 Size: 11 MB 网页链接
$Nabi Biopharmaceuticals(NABI)$ S-4 - Registration of securities, business combinations Filed: 2017-12-12 AccNo: 0001437749-17-020581 Size: 14 MB 网页链接
$Nabi Biopharmaceuticals(NABI)$ 8-K - Current report Filed: 2017-11-30 AccNo: 0001437749-17-019987 Size: 68 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Nabi Biopharmaceuticals(NABI)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-11-09 AccNo: 0001019056-17-000749 Size: 175 KB 网页链接
$Nabi Biopharmaceuticals(NABI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-11-07 AccNo: 0001437749-17-018561 Size: 2 MB 网页链接
$Nabi Biopharmaceuticals(NABI)$ 8-K - Current report Filed: 2017-11-02 AccNo: 0001437749-17-018167 Size: 167 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接